Loading…
Omada Health, Inc. is projected to rise to $31.09 by 2027, a +35% move from its current price of $23.08. OMDA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $22.51 | $23.11 | $23.72 | +0.11% |
| Jul 13 | $22.30 | $23.13 | $24.00 | +0.23% |
| Jul 14 | $22.14 | $23.16 | $24.23 | +0.34% |
| Jul 15 | $22.01 | $23.19 | $24.42 | +0.46% |
| Jul 16 | $21.90 | $23.21 | $24.60 | +0.57% |
| Jul 17 | $21.80 | $23.24 | $24.77 | +0.69% |
| Jul 18 | $21.72 | $23.27 | $24.92 | +0.81% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.72 | $23.27 | $24.92 | +0.81% |
| Week 2 | $21.28 | $23.45 | $25.85 | +1.62% |
| Week 3 | $20.99 | $23.64 | $26.63 | +2.43% |
| Week 4 | $20.77 | $23.83 | $27.35 | +3.26% |
| Week 5 | $20.60 | $24.02 | $28.02 | +4.09% |
| Week 6 | $20.46 | $24.22 | $28.66 | +4.93% |
| Week 7 | $20.35 | $24.41 | $29.29 | +5.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.
The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Omada Health, Inc. (OMDA) is a healthcare company with a current price of $22.62 and a market cap of $1.34B. It is ranked 2356 by market capitalization.
The forecasted price outlook shows an upward trajectory across multiple years, beginning with a 2026 average of $22.62 and climbing in subsequent years to higher targets (e.g., 2027 avg $30.22, 2028 avg $42.67, 2029 avg $58.64, 2030 avg $67.51, 2031 avg $79.92, 2032 avg $86.37, 2033 avg $95.54, 2034 avg $112.20, 2035 avg $128.94, 2040 avg $215.08, and 2050 avg $614.02).
Max targets in the forecast also rise, with 2026 max $36.13, 2030 max $106.34, 2040 max $409.78, and 2050 max $1,307.03, supporting a bullish longer-term view across sentiment labels (with Neutral in 2026 and Bullish thereafter).
A major floor 50.6% below — a decisive break under it would weaken the trend.
The nearest floor, 25.9% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key OMDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OMDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.13 | Sell | $23.03 | Buy |
| MA 10 | $22.52 | Buy | $22.23 | Buy |
| MA 20 | $20.16 | Buy | $20.85 | Buy |
| MA 50 | $17.96 | Buy | $18.53 | Buy |
| MA 100 | $15.56 | Buy | $17.19 | Buy |
| MA 200 | $17.14 | Buy | $17.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 77.73 | Sell |
| Stoch RSI (14) | 84.05 | Sell |
| CCI (20) | 88.19 | Neutral |
| Williams %R (14) | -4.85 | Info |
| MACD (12,26,9) | 0.27 | Buy |
| ROC (12) | 27.21 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 95.15 | Sell |
| TRIX (15) | 1.12 | Buy |
| Awesome (5,34) | 4.09 | Buy |
| Ultimate (7,14,28) | 80.98 | Sell |
| Momentum (10) | 4.38 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 23.53 | Sell |
| ADX (14) | 40.20 | Buy |
| ATR (14) | 0.44 | Info |
The 30-day technical picture is bullish with an RSI(14) of 80, signaling strong near-term momentum. The stock trades above key moving averages, with a SMA50 of $16.94 and a SMA200 of $17.14, suggesting a constructive trend.
Near-term support is at $16.10, while resistance sits at $22.62. The 30-day price range spans from $18.53 to $27.62, indicating room for movement within a bullish framework while approaching the current price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.94 | $23.08 | $35.62 | 0% | Neutral | |
| $24.31 | $31.09 | $42.34 | +35% | Bullish | |
| $31.69 | $41.93 | $59.59 | +82% | Bullish | |
| $42.05 | $57.24 | $84.11 | +148% | Bullish | |
| $48.15 | $67.22 | $101.57 | +191% | Bullish | |
| $54.96 | $78.50 | $121.54 | +240% | Bullish | |
| $59.12 | $86.29 | $136.54 | +274% | Bullish | |
| $64.86 | $96.60 | $155.89 | +319% | Bullish | |
| $73.16 | $111.08 | $182.53 | +381% | Bullish | |
| $83.04 | $128.45 | $214.62 | +457% | Bullish | |
| $126.74 | $213.46 | $382.40 | +825% | Bullish | |
| $305.83 | $598.75 | $1,186.16 | +24.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.94 | $23.08 | $28.19 | +0.00% |
| August 2026 | $20.99 | $24.91 | $30.45 | +7.92% |
| September 2026 | $21.41 | $25.62 | $31.73 | +2.87% |
| October 2026 | $21.42 | $25.81 | $32.32 | +0.75% |
| November 2026 | $22.15 | $26.87 | $33.95 | +4.08% |
| December 2026 | $22.91 | $27.95 | $35.62 | +4.03% |
Click any year to see its month-by-month OMDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OMDA is projected to trade between $10.94 and $35.62, averaging $23.08 — a potential gain of 0% from today's $23.08. Price action looks broadly range-bound.
Omada Health, Inc.'s 2027 outlook centres on $31.09, within a $24.31 to $42.34 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, OMDA could reach as high as $59.59, with a base case around $41.93 and support toward $31.69 — roughly +82% from $23.08. Momentum favours further upside here.
Expect OMDA to range from $42.05 to $84.11 through 2029. The $57.24 average target implies a +148% move from current prices. That is up +37% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OMDA price prediction for 2030 points to an average of $67.22 (low $48.15, high $101.57) — a potential gain of +191% on today's $23.08. Momentum favours further upside here.
In 2031, OMDA is projected to trade between $54.96 and $121.54, averaging $78.50 — a potential gain of +240% from today's $23.08. That is up +17% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Omada Health, Inc.'s 2032 outlook centres on $86.29, within a $59.12 to $136.54 range. That is up +10% on the projected 2031 average. That marks a +274% change versus current levels. Momentum favours further upside here.
By 2033, OMDA could reach as high as $155.89, with a base case around $96.60 and support toward $64.86 — roughly +319% from $23.08. Buyers look set to stay in control over this stretch.
Expect OMDA to range from $73.16 to $182.53 through 2034. The $111.08 average target implies a +381% move from current prices. That is up +15% on the projected 2033 average. Momentum favours further upside here.
The OMDA price prediction for 2035 points to an average of $128.45 (low $83.04, high $214.62) — a potential gain of +457% on today's $23.08. Buyers look set to stay in control over this stretch.
In 2040, OMDA is projected to trade between $126.74 and $382.40, averaging $213.46 — a potential gain of +825% from today's $23.08. That is up +66% on the projected 2035 average. Momentum favours further upside here.
Omada Health, Inc.'s 2050 outlook centres on $598.75, within a $305.83 to $1,186.16 range. That is up +181% on the projected 2040 average. That marks a +24.9x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OMDA today (≈ 43.327556 OMDA) could be worth
$25,942.26
+$24,942.26 (+2494%) by 2050 · US Dollar
Based on the average projected OMDA price of $598.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OMDAwould be worth at today's price.
$1,000 invested in OMDA on Jul 10, 2025 (≈ 55.803571 OMDA) would be worth
$1,287.95
+$287.95 (+28.8%) today · 1.29× · US Dollar
Based on a OMDA entry price of $17.92 vs. today's $23.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.39 | $1,030.82 | +3.1% |
| 1 month ago | $17.1 | $1,349.71 | +35.0% |
| 3 months ago | $11.41 | $2,022.79 | +102.3% |
| 6 months ago | $16.12 | $1,431.76 | +43.2% |
| 1 year ago | $17.92 | $1,287.95 | +28.8% |
| All time (1.1y) ago | $23 | $1,003.48 | +0.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OMDA forecast.
Our base-case forecast reaches $46.00 around 2029.
Implied market cap at $46.00: $2.73B
The multi-year forecast depicts a pronounced upside path, with bullish sentiment across most years and rising average prices toward the end of the decade and beyond. For 2030, the Avg is $67.51 with an ROI of 198.5, and for 2040, the Avg is $215.08 with an ROI of 850.9. By 2050, the Avg is $614.02 with an ROI of 2614.5, underscoring a substantial long-run upside if the projections materialize.
The years leading up to 2030 show steady growth in Avg values (e.g., 2027 $30.22, 2028 $42.67, 2029 $58.64, 2031 $79.92), reflecting an extended bullish trajectory. These figures illustrate a path of significant appreciation from the current level, albeit accompanied by the typical uncertainty inherent in long-term forecasts.
These are estimates and not guarantees. Actual outcomes depend on market conditions and other factors; investors should consider these projections as illustrative and exercise prudent risk assessment.
Tap a question to reveal the answer.
Avg $67.51; Min $46.47; Max $106.34; ROI 198.5; sentiment BULLISH.
The forecast shows bullish sentiment across many years with rising Avg prices (e.g., 2027 $30.22, 2028 $42.67, 2030 $67.51) and positive ROI figures (e.g., 33.6 in 2027, 198.5 in 2030), though 2026 is Neutral. These are estimates, not guarantees.
The forecast max for 2030 is $106.34, which is below $110.
Market cap $1.34B; rank 2356.
Omada Health, Inc. Community Discussion
0Share your Omada Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.